Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Spinraza™ (nusinersen) – New Orphan Drug Approval
December 23, 2016 – Biogen announced the FDA approval of Spinraza (nusinersen) injection, for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.
